THY1 and infantile convulsions and choreoathetosis: In conclusion, we emphasize that CD90 confers aggressiveness in iCCA and that the interaction with TGF-β1 could be a characteristic on which to stratify patients with iCCA who are suitable for combination therapy, paving the way toward the adoption of new personalized therapeutic strategies.